Key Takeaways

  • Wegovy (semaglutide 2.4 mg) is the first FDA-approved once-weekly injection for chronic weight management, with STEP trial data showing average weight loss of about 15% over 68 weeks.
  • Wegovy injections received Thai FDA approval in 2023 and is suitable for adults with a BMI of 30 or higher, or 27 with a weight-related condition.
  • H.U.M. Clinic offers doctor-supervised Wegovy treatment for weight loss in Bangkok with body composition analysis, monthly progress tracking, transparent pricing, and cold-chain handling.

Weight loss is rarely just about willpower. For many people with obesity or excess weight tied to other health conditions, the body’s appetite signals work against them at every meal. Wegovy weight loss treatment changes that by working on the same hormonal pathway your body uses to feel full.

The First FDA-Approved Weekly Injection for Obesity Treatment

Looking to get Wegovy injection in Bangkok or find the best price for Wegovy in Thailand? At H.U.M. Clinic, we offer FDA-approved weight loss treatment with Wegovy. The treatment is combined with a weight loss injection consultation in our Bangkok clinic and expert medical guidance every step of the way.

Our experienced doctors specialize in Semaglutide-based weight loss protocols, ensuring that each patient receives personalized advice, ongoing health monitoring, and professional support to achieve safe, sustainable, and long-term fat loss results.

what is wegovy and how does it work

Wegovy is a brand name for Semaglutide, a GLP-1 receptor agonist developed specifically for weight management for individuals with overweight or obesity issues. The medication is produced by Novo Nordisk, a global pharmaceutical company headquartered in Denmark, known for its leadership in diabetes and obesity treatments.

Wegovy is administered as a once-weekly subcutaneous injection, conveniently delivered in a pre-filled pen device designed for self-injection at home. This makes it easy and practical for long-term use. 

The drug is FDA-approved in the United States for chronic weight management in adults with: 

  • BMI ≥30 kg/m², or 
  • BMI ≥27 kg/m² with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol) 

Wegovy injection has been studied extensively in humans through the STEP clinical trial program, which began in 2018 and continued through 2023, involving over 17,000 participants globally. These trials provided strong evidence of Wegovy’s effectiveness and safety across a wide range of populations, including people with diabetes and heart disease, adolescents, and patients from East Asia, including Thailand.

With its scientific backing and ease of use, Wegovy injection has quickly become one of the most trusted and effective weight loss treatments available today. 

Wegovy vs. Ozempic What’s the Difference

How does Wegovy work in the body? Wegovy mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite and glucose metabolism. As a GLP-1 analog, Wegovy:

  • Reduces hunger and appetite
  • Slows gastric emptying
  • Improves blood sugar control
  • Enhances satiety after meals

The result is a significant reduction in caloric intake, leading to substantial weight loss over time

Wegovy’s effectiveness has been proven in several key clinical trials, most notably the STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program.

  • STEP 1 Trial (2021, New England Journal of Medicine)
    • Participants: 1,961 adults without diabetes
    • Results: Average weight loss of 14.9% from baseline
    • Nearly 70% lost ≥10% of their starting weight
    • Over 30% lost ≥20% of their starting weight
  • STEP 3 Trial (2021) combined Semaglutide with intensive behavioral therapy, yielding even higher results with an average weight loss of 16% from baseline.
    • Weight loss with Wegovy often plateaus after 6–12 months and remains stable with ongoing treatment.

Most people start to notice reduced appetite within the first few weeks of treatment, often before significant weight changes appear on the scale. Measurable weight loss typically becomes visible between weeks 8 and 12, once the dose has been titrated to a clinically active level. The full benefit usually emerges between months 6 and 12, with continued slower losses possible into the second year of treatment.

Wegovy (semaglutide 2.4 mg) has been studied in one of the most comprehensive obesity research programs ever — the STEP trial series. These global studies involved thousands of people of different ages, ethnicities, and health conditions. The results show Wegovy is not only effective for weight loss but also offers major health benefits for people with diabetes, pre-diabetes, heart issues, and even adolescents. 

Key Findings from STEP Trials: 

  • STEP 1 – People without diabetes lost an average of 15% of their body weight over 68 weeks using Wegovy plus healthy lifestyle support. 
  • STEP 2 – Adults with type 2 diabetes lost up to 10% of their weight, showing Wegovy’s strong effect even in insulin-resistant conditions. 
  • STEP 3 – Adding intensive behavioral therapy (IBT) led to even more success: average weight loss reached 16%
  • STEP 4 & 5 – Wegovy helped patients maintain weight loss over the long term, with lasting health improvements. 
  • STEP 6 & 11 – Clinical trials conducted in Thailand, Korea, and East Asia confirmed Wegovy works just as effectively in Asian populations
  • STEP 7 – Studied Wegovy in a global population including China, Brazil, and Korea, reinforcing its broad international benefit. 
  • STEP 8 – Compared Wegovy with liraglutide (Saxenda) and showed that Wegovy led to greater weight loss with fewer injections (once weekly vs. daily). 
  • STEP 9 – Explored Wegovy’s potential to help with knee osteoarthritis in obese patients. 
  • STEP 10 – Showed Wegovy helped reverse pre-diabetes in many participants, lowering long-term diabetes risk.

Additional Studies: 

  • STEP UP / T2D – Tested a higher dose (7.2 mg) of Semaglutide for patients with type 2 diabetes, showing further weight and glucose control benefits. 
  • STEP TEENS – Wegovy was tested in adolescents aged 12–17 with obesity. Results showed similar 15–16% weight loss, with a safety profile similar to adults. 
  • SELECT Trial – Aimed to assess Wegovy’s effect on heart health (CV outcomes). Early data shows reduced heart disease risk in overweight adults. 
  • STEP HFpEF & HFpEF DM – Focused on people with heart failure with preserved ejection fraction, with and without diabetes. Wegovy improved both weight and heart-related symptoms, offering new hope for complex patients. 

In summary, Wegovy is not just for losing weight, it’s proven to help improve blood sugar, reverse pre-diabetes, improve heart function, and support adolescents and patients with chronic diseases. With over a dozen high-quality studies, it’s one of the most evidence-based weight loss treatments available today. 

What Are the Indications for Wegovy? 

Wegovy is approved for: 

  • Adults with BMI ≥30 kg/m² 
  • Adults with BMI ≥27 kg/m² and at least one weight-related condition (e.g., type 2 diabetes, hypertension, dyslipidemia) 

What Are the Contraindications for Wegovy? 

Do not use Wegovy if you have: 

  • History of medullary thyroid carcinoma or MEN2 syndrome 
  • Severe gastrointestinal disease 
  • Pregnancy or breastfeeding 
  • Hypersensitivity to Semaglutide or any components of the formulation 

A thorough doctor consultation at H.U.M. Clinic is required before prescribing Wegovy.

What Are the Side Effects of Wegovy

Common side effects include: 

  • Nausea 
  • Vomiting 
  • Diarrhea or constipation 
  • Headache 
  • Fatigue
  • Injection site reactions

Most side effects improve as your body adjusts to the medication. 

  • Start with a low dose and gradually titrate as per doctor’s instructions 
  • Avoid greasy or heavy meals during the first few weeks 
  • Stay hydrated 
  • Report any serious symptoms (like persistent vomiting or abdominal pain) to your doctor immediately 

Proper dose titration is essential to maximize weight loss results while minimizing side effects from Wegovy (Semaglutide). At H.U.M. Clinic, our medical team provides personalized dose adjustment plans tailored to each individual’s tolerance, goals, and health condition.

The standard titration protocol, based on clinical trials and FDA guidelines, gradually increases the dose over 16 weeks to reach the target maintenance dose of 2.4 mg once weekly: 

Week Dose (Semaglutide)
1–4 0.25 mg once weekly 
5–8 0.5 mg once weekly 
9–12 1.0 mg once weekly 
13–16 1.7 mg once weekly 
Week 17+ 2.4 mg once weekly (maintenance dose) 

This gradual titration helps your body adjust to the medication and significantly reduces the risk of gastrointestinal side effects.

Some patients may need a slower titration pace or may temporarily pause dose escalation if side effects occur. At H.U.M. Clinic, we monitor your progress closely and adjust your Wegovy injection dose based on:

  • Side effect tolerance 
  • Weight loss response 
  • Blood sugar or blood pressure changes 
  • Lab test results (as needed) 

We ensure that you are never left on your own; every dose decision is guided by our doctors. 

  1. Book a consultation with one of our medical doctors 
  1. Receive a health screening and body composition check 
  1. Assess suitability for Wegovy weight loss injections
  1. Start with weekly injections, guided and monitored by our expert team 
  1. Follow-up monthly with health tracking and progress review
cost of Wegovy weight loss injections in Bangkok

At H.U.M. Clinic, we are committed to transparent, honest pricing for all our treatments. If you’re looking for Wegovy weight loss injections in Bangkok, here’s a clear breakdown of what you can expect when starting treatment with us:

  • Initial doctor consultation + body composition analysis: 1,500 THB — Includes medical evaluation, personalized weight loss planning, and full body composition assessment.
  • Optional blood tests: Performed only when medically indicated; prices vary depending on individual needs.
  • Wegovy injection medication starts at 9,900 THB per month — Includes the Wegovy injection pen, cold-chain handling, and doctor-supervised treatment.
  • Shipping with temperature control available for clients across Thailand.

Note: In many private hospitals, the price of Wegovy injections for weight loss and its related services may be significantly higher than at our clinic. We encourage clients to compare prices, value, personalized care they receive at H.U.M. Clinic.

Wegovy vs. Ozempic: What’s the Difference?

If you’re comparing Wegovy and Ozempic, it’s important to know that both medications contain Semaglutide, a GLP-1 receptor agonist that helps control appetite, reduce blood sugar, and support weight loss. However, they are designed for different medical uses and dosing strategies. If you want a dual-incretin alternative to Semaglutide, you can also get Mounjaro in Bangkok at our clinic.

What is Different?

  • Wegovy is FDA-approved for chronic weight management in people with overweight or obesity. It is prescribed at a higher target dose of 2.4 mg once weekly, which is optimized for significant fat loss and long-term weight control.
  • Ozempic is approved for type 2 diabetes treatment and is generally used at lower doses up to 2.0 mg once weekly to help lower blood sugar and reduce cardiovascular risk.

What is Similar?

Despite the differences in indication and dosage, Wegovy and Ozempic share several key similarities:

  • Same active ingredient: Both contain Semaglutide
  • Same mechanism of action: Both mimic GLP-1, which helps regulate appetite and blood sugar
  • Same administration method: Both are once-weekly injectable pens
  • Same manufacturer: Developed by Novo Nordisk, a global pharma company from Denmark

Are They Interchangeable?

Wegovy and Ozempic are not officially interchangeable, but they can be used off-label for similar outcomes, especially in weight management. However, because the dosages and approved indications differ, any substitution must be done under medical supervision.

If you’re considering using Ozempic or Wegovy for weight loss, or switching between the two, our doctors at H.U.M. Clinic in Bangkok can guide you on a safe and effective dosing strategy tailored to your health status and goals.

What Are the Other Weight Loss Options Available at H.U.M. Clinic?

In addition to Wegovy, we offer:

  • Tirzepatide (Mounjaro, Zepbound)
  • Testosterone optimization (TRT) programs
  • Peptide weight loss programs
  • Fat-burning injections and IV drips
  • Custom nutrition and fitness support

Every program is tailored to your unique body and goals.

Wegovy vs Mounjaro (Tirzepatide): Which Is Better?

Benefits You Get When Starting Wegovy Injections at H.U.M. Clinic

  • ✅ Body composition analysis and monthly progress tracking
  • ✅ Comprehensive health assessment and doctor oversight
  • ✅ Good price, no hidden fees
  • ✅ Authorized supplier, genuine product only
  • ✅ Cold chain shipping with temperature control
  • ✅ Doctor-guided support every step of the way

For your appointment to learn more about Wegovy injection for weight loss, H.U.M. Clinic offers physician-supervised semaglutide treatment with English-speaking doctors near BTS Asok and MRT Sukhumvit. Treatment is structured as an ongoing program rather than a single transaction, with monthly check-ins built into the cost.

To book your consultation, contact H.U.M. Clinic Bangkok via LINE @humlinic, WhatsApp, phone at 098 983 2949, or email at [email protected].

Frequently Asked Questions (FAQs) About Wegovy Injections for Weight Loss

Q: Is Wegovy injection for weight loss available in Thailand?

A: Yes. Wegovy received Thai FDA approval in 2023 and was officially launched in Thailand in 2025, the first Southeast Asian country to receive the brand. It is available through licensed clinics and hospitals, including H.U.M. Clinic in Bangkok, with a doctor’s prescription.

Q: I’m a foreigner visiting Thailand. Can I get Wegovy injections at H.U.M. Clinic and bring them back to my country?

A: Yes, foreigners are welcome at H.U.M. Clinic. We regularly treat international clients who are looking for Wegovy for weight loss in Bangkok. Our licensed doctors will evaluate your case, and if suitable, prescribe Wegovy as part of a safe treatment plan. We also provide official medical documentation (including prescription and treatment summary) to help you legally carry the medication back to your country, depending on the regulations of your home country. Please check your local customs and import rules before traveling.

Q: Can I buy Wegovy injections over the counter in Thailand?

A: No. Wegovy is a prescription medication and must be administered under a doctor’s supervision.

Q: How much weight can I lose on Wegovy injection treatment?

A: In the STEP 1 trial, adults without diabetes lost an average of about 15% of their body weight over 68 weeks on Wegovy combined with lifestyle changes. Roughly 70% of participants lost at least 10% of their starting weight. Individual results vary based on starting weight, diet, activity level, and how well the body responds to semaglutide.

Q: How long will I need to use Wegovy for weight loss?

A: Clinical trials suggest long-term use is needed to maintain weight loss. Your doctor will help determine the right duration.

Q: Will the weight come back if I stop Wegovy?

A: Weight regain is common if lifestyle changes are not maintained. At H.U.M. Clinic, we provide support to help prevent weight rebound.

Q: Can I ship Wegovy to my home?

A: Yes. We offer cold-chain shipping with temperature control, ensuring the medication remains safe and effective.

Q: Is Wegovy better than Ozempic for weight loss?

A: Yes. Wegovy is optimized for weight loss, with a higher target dose than Ozempic.